Search Results
Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023)
[Webinar] NS Pharma Provides Viltolarsen Update - November 2019
VILTEPSO (viltolarsen)- Duchenne muscular dystrophy (DMD)
Trial Update: Exon Skipping - WAVE Life Sciences [PPMD's 2017 Connect Conference]
Trials in Duchenne - Reveragen [PPMD's 2016 Connect Conference]
اربعة ادوية للدوشن
webinar on "Duchenne muscular dystrophy (DMD)-Current trends in management" by AIIMS Nagpur in Hindi
![[Webinar] NS Pharma Provides Viltolarsen Update - November 2019](https://img.youtube.com/vi/6r1_agRAAx4/hqdefault.jpg)
![Trial Update: Exon Skipping - WAVE Life Sciences [PPMD's 2017 Connect Conference]](https://img.youtube.com/vi/_oMbK1WAoJk/hqdefault.jpg)
![Trials in Duchenne - Reveragen [PPMD's 2016 Connect Conference]](https://img.youtube.com/vi/sLCMAGdCs0s/hqdefault.jpg)
